UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Management and complications of tubo-ovarian abscess

Author
Richard H Beigi, MD, MSc
Section Editors
Howard T Sharp, MD
Daniel J Sexton, MD
Deputy Editor
Sandy J Falk, MD, FACOG

INTRODUCTION

A tubo-ovarian abscess (TOA) is an inflammatory mass involving the fallopian tube, ovary and, occasionally, other adjacent pelvic organs (eg, bowel, bladder) [1]. These abscesses are found most commonly in reproductive age women and typically result from upper genital tract infection.

TOA is a serious and potentially life-threatening condition. Aggressive medical and/or surgical therapy is required and rupture of an abscess may result in sepsis. Prior to the advent of broad-spectrum antibiotics and modern surgical practice, the mortality rate associated with TOA was approximately 50 percent or higher [2,3].

The mortality rate approaches zero for abscesses that are not ruptured. For patients with ruptured abscesses, current mortality rates have not been reported, but data from the 1960s suggest the rate may be as high as 1.7 to 3.7 percent [2,4,5].

Treatment modalities for TOA include intensive antibiotic therapy, minimally-invasive drainage procedures, invasive surgery, or a combination of these interventions. The large majority of small abscesses (<9 cm in diameter) resolves with antibiotic therapy alone.

The management of tubo-ovarian abscesses is reviewed here. The epidemiology, diagnosis and evaluation of tubo-ovarian abscesses are discussed separately. Other manifestations of pelvic inflammatory disease are discussed separately. (See "Epidemiology, clinical manifestations, and diagnosis of tubo-ovarian abscess" and "Pelvic inflammatory disease: Pathogenesis, microbiology, and risk factors" and "Pelvic inflammatory disease: Clinical manifestations and diagnosis" and "Pelvic inflammatory disease: Treatment" and "Long-term complications of pelvic inflammatory disease".)

                      

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Mon Jul 11 00:00:00 GMT+00:00 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. Granberg S, Gjelland K, Ekerhovd E. The management of pelvic abscess. Best Pract Res Clin Obstet Gynaecol 2009; 23:667.
  2. PEDOWITZ P, BLOOMFIELD RD. RUPTURED ADNEXAL ABSCESS (TUBOOVARIAN) WITH GENERALIZED PERITONITIS. Am J Obstet Gynecol 1964; 88:721.
  3. VERMEEREN J, TE LINDE RW. Intraabdominal rupture of pelvic abscesses. Am J Obstet Gynecol 1954; 68:402.
  4. Rosen M, Breitkopf D, Waud K. Tubo-ovarian abscess management options for women who desire fertility. Obstet Gynecol Surv 2009; 64:681.
  5. Paik CK, Waetjen LE, Xing G, et al. Hospitalizations for pelvic inflammatory disease and tuboovarian abscess. Obstet Gynecol 2006; 107:611.
  6. Lareau SM, Beigi RH. Pelvic inflammatory disease and tubo-ovarian abscess. Infect Dis Clin North Am 2008; 22:693.
  7. Landers DV, Sweet RL. Tubo-ovarian abscess: contemporary approach to management. Rev Infect Dis 1983; 5:876.
  8. Reed SD, Landers DV, Sweet RL. Antibiotic treatment of tuboovarian abscess: comparison of broad-spectrum beta-lactam agents versus clindamycin-containing regimens. Am J Obstet Gynecol 1991; 164:1556.
  9. Ginsburg DS, Stern JL, Hamod KA, et al. Tubo-ovarian abscess: a retrospective review. Am J Obstet Gynecol 1980; 138:1055.
  10. Sweet RL, Ohm-Smith M, Landers DV, Robbie MO. Moxalactam versus clindamycin plus tobramycin in the treatment of obstetric and gynecologic infections. Am J Obstet Gynecol 1985; 152:808.
  11. Sweet RL, Schachter J, Landers DV, et al. Treatment of hospitalized patients with acute pelvic inflammatory disease: comparison of cefotetan plus doxycycline and cefoxitin plus doxycycline. Am J Obstet Gynecol 1988; 158:736.
  12. Sweet RL. Soft tissue infection and pelvic abscess. In: Infectious diseases of the female genital tract, 5th ed, Sweet RL, Gibbs RS (Eds), Lippincott Williams and Wilkins, Philadelphia 2009.
  13. Wiesenfeld HC, Sweet RL. Progress in the management of tuboovarian abscesses. Clin Obstet Gynecol 1993; 36:433.
  14. Cohen CR, Sinei S, Reilly M, et al. Effect of human immunodeficiency virus type 1 infection upon acute salpingitis: a laparoscopic study. J Infect Dis 1998; 178:1352.
  15. Kamenga MC, De Cock KM, St Louis ME, et al. The impact of human immunodeficiency virus infection on pelvic inflammatory disease: a case-control study in Abidjan, Ivory Coast. Am J Obstet Gynecol 1995; 172:919.
  16. Dewitt J, Reining A, Allsworth JE, Peipert JF. Tuboovarian abscesses: is size associated with duration of hospitalization & complications? Obstet Gynecol Int 2010; 2010:847041.
  17. Gerzof SG, Robbins AH, Johnson WC, et al. Percutaneous catheter drainage of abdominal abscesses: a five-year experience. N Engl J Med 1981; 305:653.
  18. Gerzof SG, Johnson WC, Robbins AH, Nabseth DC. Expanded criteria for percutaneous abscess drainage. Arch Surg 1985; 120:227.
  19. Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64:1.
  20. Joiner KA, Lowe BR, Dzink JL, Bartlett JG. Antibiotic levels in infected and sterile subcutaneous abscesses in mice. J Infect Dis 1981; 143:487.
  21. Itani KM, Wilson SE, Awad SS, et al. Ertapenem versus cefotetan prophylaxis in elective colorectal surgery. N Engl J Med 2006; 355:2640.
  22. Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010; 50:133.
  23. Pelak BA, Citron DM, Motyl M, et al. Comparative in vitro activities of ertapenem against bacterial pathogens from patients with acute pelvic infection. J Antimicrob Chemother 2002; 50:735.
  24. Solomkin J, Teppler H, Graham DR, et al. Treatment of polymicrobial infections: post hoc analysis of three trials comparing ertapenem and piperacillin-tazobactam. J Antimicrob Chemother 2004; 53 Suppl 2:ii51.
  25. An MM, Zou Z, Shen H, et al. Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trials. BMC Infect Dis 2009; 9:193.
  26. McNeeley SG, Hendrix SL, Mazzoni MM, et al. Medically sound, cost-effective treatment for pelvic inflammatory disease and tuboovarian abscess. Am J Obstet Gynecol 1998; 178:1272.
  27. Hsu WC, Lee YH, Chang DY. Tuboovarian abscess caused by Candida in a woman with an intrauterine device. Gynecol Obstet Invest 2007; 64:14.
  28. Thaneemalai J, Asma H, Savithri DP. Salmonella tuboovarian abscess. Med J Malaysia 2007; 62:422.
  29. Myckan KA, Booth CM, Mocarski E. Pasteurella multocida bacteremia and tuboovarian abscess. Obstet Gynecol 2005; 106:1220.
  30. Worthen NJ, Gunning JE. Percutaneous drainage of pelvic abscesses: management of the tubo-ovarian abscess. J Ultrasound Med 1986; 5:551.
  31. Nelson AL, Sinow RM, Renslo R, et al. Endovaginal ultrasonographically guided transvaginal drainage for treatment of pelvic abscesses. Am J Obstet Gynecol 1995; 172:1926.
  32. Teisala K, Heinonen PK, Punnonen R. Transvaginal ultrasound in the diagnosis and treatment of tubo-ovarian abscess. Br J Obstet Gynaecol 1990; 97:178.
  33. Nelson AL, Sinow RM, Oliak D. Transrectal ultrasonographically guided drainage of gynecologic pelvic abscesses. Am J Obstet Gynecol 2000; 182:1382.
  34. vanSonnenberg E, D'Agostino HB, Casola G, et al. US-guided transvaginal drainage of pelvic abscesses and fluid collections. Radiology 1991; 181:53.
  35. Harisinghani MG, Gervais DA, Maher MM, et al. Transgluteal approach for percutaneous drainage of deep pelvic abscesses: 154 cases. Radiology 2003; 228:701.
  36. Gjelland K, Ekerhovd E, Granberg S. Transvaginal ultrasound-guided aspiration for treatment of tubo-ovarian abscess: a study of 302 cases. Am J Obstet Gynecol 2005; 193:1323.
  37. Levenson RB, Pearson KM, Saokar A, et al. Image-guided drainage of tuboovarian abscesses of gastrointestinal or genitourinary origin: a retrospective analysis. J Vasc Interv Radiol 2011; 22:678.
  38. Goharkhay N, Verma U, Maggiorotto F. Comparison of CT- or ultrasound-guided drainage with concomitant intravenous antibiotics vs. intravenous antibiotics alone in the management of tubo-ovarian abscesses. Ultrasound Obstet Gynecol 2007; 29:65.
  39. Hiller N, Sella T, Lev-Sagi A, et al. Computed tomographic features of tuboovarian abscess. J Reprod Med 2005; 50:203.
  40. Yang CC, Chen P, Tseng JY, Wang PH. Advantages of open laparoscopic surgery over exploratory laparotomy in patients with tubo-ovarian abscess. J Am Assoc Gynecol Laparosc 2002; 9:327.
  41. WHO website for STI treatment guidelines: http://www.who.int/hiv/pub/sti/en/STIGuidelines2003.pdf. (Accessed on November 08, 2011).
  42. Jackson SL, Soper DE. Pelvic inflammatory disease in the postmenopausal woman. Infect Dis Obstet Gynecol 1999; 7:248.
  43. Protopapas AG, Diakomanolis ES, Milingos SD, et al. Tubo-ovarian abscesses in postmenopausal women: gynecological malignancy until proven otherwise? Eur J Obstet Gynecol Reprod Biol 2004; 114:203.
  44. Lipscomb GH, Ling FW. Tubo-ovarian abscess in postmenopausal patients. South Med J 1992; 85:696.
  45. Hoffman M, Molpus K, Roberts WS, et al. Tuboovarian abscess in postmenopausal women. J Reprod Med 1990; 35:525.
  46. Dudley AG, Lee F, Barclay D. Ovarian and tubo-ovarian abscess in pregnancy: report of a case and a review of the literature. Mil Med 1970; 135:403.
  47. Matsunaga Y, Fukushima K, Nozaki M, et al. A case of pregnancy complicated by the development of a tubo-ovarian abscess following in vitro fertilization and embryo transfer. Am J Perinatol 2003; 20:277.
  48. Stubbs RE, Monif GR. Ruptured tubo-ovarian abscess in pregnancy: recovery of a penicillinase-producing strain of Neisseria gonorrhoeae. Sex Transm Dis 1985; 12:235.
  49. Dicker D, Samuel N, Feldberg D, Goldman JA. Infected ectopic pregnancy presenting as unilateral tubo-ovarian abscess. Eur J Obstet Gynecol Reprod Biol 1984; 17:237.
  50. Davey MM, Guidozzi F. Ruptured tubo-ovarian abscess late in pregnancy. A case report. S Afr Med J 1987; 71:120.
  51. Hunt SM, Kincheloe BW, Schreier PC. Tubo-ovarian abscess in pregnancy. Obstet Gynecol 1974; 43:57.